Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Naumovska Z"'
Publikováno v:
Balkan Journal of Medical Genetics, Vol 26, Iss 2, Pp 35-40 (2024)
Clopidogrel, is a standard treatment in the prevention of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD). Clopidogrel response is highly variable, mainly due to the presence of polymorphisms in the genes inv
Externí odkaz:
https://doaj.org/article/da5b9cbc1fc540559f18a73a83586699
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 339-347 (2018)
Zorica Naumovska,1 Aleksandra K Nestorovska,1 Aleksandra Grozdanova,1 Kristina Hristova,2 Aleksandar Dimovski,1 Ljubica Suturkova,1 Zoran Sterjev1 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, SS “Cyril and Methodius”, Skopje, Rep
Externí odkaz:
https://doaj.org/article/71705794ea1a4bbcb90b5423aa01489b
Autor:
Nestorovska Kapedanovska A., Jakovski K., Naumovska Z., Bajro Hiljadnikova M., Sterjev Z., Eftimov A., Geskovska Matevska N., Suturkova L., Dimitrovski K., Labacevski N., Dimovski A. J.
Publikováno v:
Balkan Journal of Medical Genetics, Vol 17, Iss 2, Pp 5-14 (2014)
Genetic variation in the regulation, expression and activity of genes coding for Phase I, Phase II drug metabolizing enzymes (DMEs) and drug targets, can be defining factors for the variability in both the effectiveness and occurrence of drug therapy
Externí odkaz:
https://doaj.org/article/633d2bff21fb41b298cc9b4a3b8de63f
Autor:
Sterjev Z, Trencevska GK, Cvetkovska E, Petrov I, Kuzmanovski I, Ribarska JT, Nestorovska AK, Matevska N, Naumovska Z, Jolevska-Trajkovic S, Dimovski A, Suturkova L
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2012, Iss default, Pp 191-196 (2012)
Zoran Sterjev1, Gordana Kiteva Trencevska2, Emilija Cvetkovska2, Igor Petrov2, Igor Kuzmanovski2, Jasmina T Ribarska3, Aleksandra K Nestorovska1, Nadica Matevska1, Zorica Naumovska1, Suzana Jolevska-Trajkovic3, Aleksandar Dimovski1, Ljubica Suturkova
Externí odkaz:
https://doaj.org/article/6ba46e269dde456294c428af6f671628
Autor:
Kapedanovska Nestorovska Aleksandra, Jakjovski Krume, Naumovska Zorica, Sterjev Zoran, Geskovska Nadica Matevska, Mladenovska Kristina, Suturkova Ljubica, Dimovski Aleksandar
Publikováno v:
Acta Pharmaceutica, Vol 69, Iss 3, Pp 399-412 (2019)
The relative contribution of CYP2C9 allelic variants to the pharmacokinetics (PK) of ibuprofen (IBP) enantiomers has been studied extensively, but the potential clinical benefit of pharmacogenetically guided IBP treatment is not evident yet. The role
Externí odkaz:
https://doaj.org/article/f2e49c5c14c346c89871f395269d2d7d